Latest Insider Transactions at Change Healthcare Inc. (CHNG)
This section provides a real-time view of insider transactions for Change Healthcare Inc. (CHNG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Change Healthcare Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Change Healthcare Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Roderick H. O'Reilly Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,750
+16.52%
|
-
|
|
Dec 28
2021
|
Neil E. De Crescenzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,976
-6.78%
|
$1,553,496
$21.44 P/Share
|
|
Dec 28
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
187,990
+14.7%
|
-
|
|
Nov 19
2021
|
Paul Rareshide SVP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
4,579
-13.49%
|
$91,580
$20.6 P/Share
|
|
Nov 11
2021
|
Steven B. Martin EVP, Enterprise Technology |
SELL
Open market or private sale
|
Direct |
8,857
-3.27%
|
$185,997
$21.35 P/Share
|
|
Aug 01
2021
|
Kriten Joshi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,656
-3.03%
|
$181,776
$21.71 P/Share
|
|
Aug 01
2021
|
Kriten Joshi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,656
+2.94%
|
-
|
|
Jun 22
2021
|
Robert Zollars Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Phillip W. Roe Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Philip M Pead Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+6.99%
|
-
|
|
Jun 22
2021
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Bansi Nagji Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+18.41%
|
-
|
|
Jun 22
2021
|
Nella Domenici Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+24.81%
|
-
|
|
Jun 22
2021
|
Kriten Joshi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,518
-10.8%
|
$770,914
$23.15 P/Share
|
|
Jun 22
2021
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,314
+19.74%
|
-
|
|
Jun 22
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,942
-10.61%
|
$297,666
$23.15 P/Share
|
|
Jun 22
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,888
+21.24%
|
-
|
|
Jun 22
2021
|
Neil E. De Crescenzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
107,249
-10.62%
|
$2,466,727
$23.15 P/Share
|
|
Jun 22
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
272,550
+21.25%
|
-
|
|
Jun 22
2021
|
Howard L Lance Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+3.16%
|
-
|
|
Jun 22
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,535
-6.56%
|
$173,305
$23.15 P/Share
|
|
Jun 22
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,621
+17.65%
|
-
|
|
Jun 17
2021
|
Kriten Joshi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,718
-4.72%
|
$315,514
$23.07 P/Share
|
|
Jun 17
2021
|
Kriten Joshi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,718
+4.51%
|
-
|
|
Apr 01
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+35.14%
|
-
|
|
Apr 01
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+34.84%
|
-
|
|
Apr 01
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
289,473
+28.19%
|
-
|
|
Apr 01
2021
|
Steven B. Martin EVP, Enterprise Technology |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+18.2%
|
-
|
|
Apr 01
2021
|
Thomas Laur Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+28.59%
|
-
|
|
Apr 01
2021
|
Loretta A. Cecil EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+28.18%
|
-
|
|
Apr 01
2021
|
August Calhoun Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+28.57%
|
-
|
|
Apr 01
2021
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+20.49%
|
-
|
|
Apr 01
2021
|
Roderick H. O'Reilly Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+27.75%
|
-
|
|
Apr 01
2021
|
Fredrik J Eliasson EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
156,798
+28.23%
|
-
|
|
Apr 01
2021
|
Paul Rareshide SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
15,350
+31.14%
|
-
|
|
Aug 20
2020
|
Kriten Joshi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,657
-3.03%
|
$103,884
$12.93 P/Share
|
|
Aug 20
2020
|
Kriten Joshi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,657
+2.94%
|
-
|